Advancing LNP Stability, Storage & Supply Chain Strategies for Commercial mRNA Products
- Optimizing LNP composition and excipient selection to improve long-term stability, reduce cold chain burden, and support global product distribution
- Exploring real-world lessons from clinical and commercial manufacturing around storage conditions, shipping logistics, and maintaining product integrity at scale
- Discussing integrated CMC strategies to support lifecycle management, tech transfer, and commercial readiness for next-generation mRNA and LNP-enabled therapeutics